Markets:

Overview

News

Currencies

International

Treasuries

Wave Life Sciences Ltd. - Ordinary Shares (NQ:WVE)

12.91 -0.10 (-0.77%)

Streaming Delayed Price Updated: 12:08 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Wave Life Sciences Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >

This Director Sold 42,000 Shares of Wave Life Sciences for $630,000. What Investors Should Know About This Biotech Company. ↗

January 14, 2026

This biotech innovator in genetic medicines reported significant insider selling, as disclosed in recent SEC filings.

Via The Motley Fool

Topics Regulatory Compliance

Stay updated with the stocks that are on the move in today's pre-market session. ↗

January 06, 2026

Via Chartmill

In today's session, these stocks are experiencing unusual volume. ↗

December 11, 2025

In today's session, these stocks are experiencing unusual volume.

Via Chartmill

Golden Cross Alert: 3 Stocks With Major Upside Potential ↗

December 10, 2025

Via MarketBeat

The 2025 Weight-Loss Drug Gold Rush: How Eli Lilly Pulled Ahead, Novo Hit A Snag — And A Swarm Of Biotech Underdogs Are Closing In ↗

December 09, 2025

Via Stocktwits

Wave Life Sciences Stock Rockets 120% After Obesity Drug Shows Deep Fat Reduction, Muscle Gain — Traders See A ‘Blockbuster' Candidate ↗

December 08, 2025

Via Stocktwits

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

Peering Into WAVE Life Sciences's Recent Short Interest ↗

September 12, 2025

Via Benzinga

Why Wave Life Sciences Stock Crushed it Again Today ↗

December 09, 2025

There's nothing like a nearly 150% price gain to garner the attention of investors and analysts.

Via The Motley Fool

Which stocks have an unusual volume on Tuesday? ↗

December 09, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

Why Structure Therapeutics Stock Doubled and Then Some on Monday ↗

December 08, 2025

The company's investigational GLP-1 treatment performed admirably well in a phase 2b study.

Via The Motley Fool

Why Wave Life Sciences Stock Vaulted 146% Higher on Monday ↗

December 08, 2025

We have an emerging new entrant in the increasingly crowded weight loss drug space.

Via The Motley Fool

Wave Life Sciences Tumbled 19% Today, But Not Everyone’s Disappointed – Find Out Why ↗

September 03, 2025

Via Stocktwits

Biggest Stock Movers Today, Dec. 8: CFLT, UL, & More ↗

December 08, 2025

Via The Motley Fool

What's going on in today's session ↗

December 08, 2025

Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

There are notable gap-ups and gap-downs in today's session. ↗

December 08, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

December 08, 2025

Wondering what's happening in Monday's pre-market session? Find an overview in this article.

Via Chartmill

Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results

December 03, 2025

December 3, 2025 – Capricor Therapeutics (NASDAQ: CAPR) has sent shockwaves through the biotech sector today, witnessing an astonishing 535% surge in its stock price, propelling the company to an...

Via MarketMinute

These Analysts Revise Their Forecasts On Wave Life Sciences Following Q3 Results ↗

November 11, 2025

Via Benzinga

Wave Life Sciences (WVE) Earnings Transcript ↗

November 10, 2025

Wave Life Sciences (WVE) Earnings Transcript

Via The Motley Fool

Wave Life Sciences Ltd (NASDAQ:WVE) Reports Q3 2025 Earnings Miss, Stock Falls ↗

November 10, 2025

Wave Life Sciences reported mixed Q3 2025 results, missing on revenue and EPS. Despite the financial miss, the biotech highlighted strong clinical progress for its obesity and AATD programs.

Via Chartmill

Topics Earnings

Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally

November 07, 2025

The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

A Look Ahead: WAVE Life Sciences's Earnings Forecast ↗

November 07, 2025

Via Benzinga

Keep an eye on the top gainers and losers in Wednesday's session. ↗

October 29, 2025

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 29, 2025

Via Benzinga

Deep Dive Into WAVE Life Sciences Stock: Analyst Perspectives (6 Ratings) ↗

October 15, 2025

Via Benzinga

Top movers analysis one hour before the close of the markets on 2025-09-03: top gainers and losers in today's session. ↗

September 03, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Forecasting The Future: 7 Analyst Projections For WAVE Life Sciences ↗

September 03, 2025

Via Benzinga

Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday? ↗

September 03, 2025

Wave Life Sciences shares early WVE-006 trial results in alpha-1 antitrypsin deficiency, reporting durable protein production and favorable safety.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 03, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.